AXGN
AxoGen Inc
Price:  
6.04 
USD
Volume:  
210,247.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AxoGen EV/EBITDA

-210.0%
Upside

As of 2024-05-18, the EV/EBITDA ratio of AxoGen Inc (AXGN) is -21.72. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AxoGen's latest enterprise value is 295.08 mil USD. AxoGen's TTM EBITDA according to its financial statements is -13.59 mil USD. Dividing these 2 quantities gives us the above AxoGen EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 15.4x - 17.4x 16.4x
Forward P/E multiples 19.9x - 27.9x 21.8x
Fair Price (6.89) - (6.13) (6.64)
Upside -214.1% - -201.6% -210.0%
6.04 USD
Stock Price
(6.64) USD
Fair Price

AxoGen EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-17 -21.72
2024-05-16 -21.49
2024-05-15 -21.43
2024-05-14 -20.85
2024-05-13 -20.91
2024-05-10 -20.79
2024-05-09 -21.53
2024-05-08 -21.17
2024-05-07 -21.04
2024-05-06 -20.53
2024-05-03 -20.91
2024-05-02 -21.20
2024-05-01 -23.39
2024-04-30 -22.91
2024-04-29 -23.71
2024-04-26 -23.62
2024-04-25 -23.26
2024-04-24 -24.39
2024-04-23 -24.71
2024-04-22 -24.36
2024-04-19 -23.20
2024-04-18 -23.36
2024-04-17 -24.61
2024-04-16 -24.81
2024-04-15 -24.90
2024-04-12 -25.48
2024-04-11 -25.90
2024-04-10 -26.41
2024-04-09 -28.12
2024-04-08 -27.76
2024-04-05 -27.38
2024-04-04 -27.25
2024-04-03 -28.21
2024-04-02 -27.41
2024-04-01 -27.86
2024-03-28 -28.25
2024-03-27 -27.28
2024-03-26 -26.57
2024-03-25 -26.16
2024-03-22 -25.93
2024-03-21 -26.96
2024-03-20 -27.19
2024-03-19 -26.99
2024-03-18 -27.09
2024-03-15 -26.99
2024-03-14 -27.25
2024-03-13 -28.18
2024-03-12 -28.76
2024-03-11 -29.44
2024-03-08 -30.43